[Pharm-policy] Another costs of cancer trials paper

[James Love]

This is another paper that compares costs of care in clinical trials
versus regular care for cancer patients.  Jamie
 


http://asco.infostreet.com/prof/me/html/99abstracts/hsr/m_1610.htm

1999.  The Cost of Care in Cancer Clinical Trials -A Matched, Controlled
Analysis of Participation in Selected National Cooperative Group Trials.
Louis Fehrenbacher, Bruce Fireman, Liz Gruskin, Tom Ray. Division of
Research Kaiser Permanente, Northern California Region, Oakland, Calif. 

. . . The mean one year cost in $ of trial patients was $17,003 compared
to $15,516 for controls, p=0.49 (paired t-test). If randomized
autologous bone marrow transplant vs. control studies were removed, the
one year cost for trial patients (124 matched pairs) was $15,041 vs.
$15,185 for the controls. If customary prices had been paid for study
supplied chemotherapy drugs, the mean one year costs for trial patients
would have been $19,675 vs. $15,516 for controls, (p<0.01). The costs of
research infrastructure, data management, and research specific
physician time have not been included. 



-- 
James Love, Consumer Project on Technology
v. 1.202.387.8030, fax 1.202.234.5176
love@cptech.org, http://www.cptech.org